As Schering-Plough faces various hurdles, Roche's pharmaceuticals division finally sees some potential for growth after years of stasis.

FORBES: Roche And Schering's Desperate Duel

The goal in the pharmaceuticals division is to go from 600 servers to 300 and to boost utilization to as high as 70%.

FORBES: The New Barbarians

"We thought it was time we did a better job of telling our story, " says Christopher Viehbacher, president of GSK's U.S. pharmaceuticals division based in Philadelphia and Research Triangle Park, N.

FORBES: Spin Doctors